May 26, 2014 Issue | Chemical & Engineering News
 
 

Register for C&EN's Inaugural Virtual Symposium Advances in Drug Discovery and Development on Sept 24th

Featuring Keynotes Greg Verdine and Alexander Kamb, as well as others - Registration is free! http://cenm.ag/symposium

 
Copyright © 2014 American Chemical Society
 

May 26, 2014 Issue

Volume 92, Issue 21
09221-cover-LonzaFlowPlatecxd
May 26, 2014 Issue, Vol. 92 | Iss. 21
After a slow start, pharmaceutical and fine chemicals manufacturers are scaling up continuous processes for production
By Ann M. Thayer
(pp. 13-21)
Features
Business
Patient groups are finding new models for funding drug development for their diseases (pp. 27-28)
Science & Technology
With little medical input and supply challenges, states struggle to ensure capital punishment is neither cruel nor unusual (pp. 46-48)
Back Issues
 

News of the Week

Tug-of-War Over Promising Cancer Drug Candidate

Drug Discovery: Structure error threatens existing patent and clinical trials
(p.7)

Russia And China Strengthen Bonds

Petrochemicals: Sibur, Sinopec get close while Putin visits China
(p.8)

Spinning Graphene Oxide Yarns

Materials: New method turns graphene oxide films into stretchy fibers tough enough to tie into knots
(p.8)

AstraZeneca Rejects Pfizer’s Final Offer

Acquisition: Deal not sweet enough to make British firm bend
(p.9)

EPA Targets Refinery Pollution

Air Toxics: Industry blasts proposed emission rule as unjustified and costly
(p.10)

Human Placenta Has Microbiome

Microbiology: Bacterial colony makeup may affect pregnancy outcomes
(p.10)

Minnesota Bans Triclosan

Legislation: State is halting retail sales of soaps containing antibacterial chemical
(pp. 11-12)

Rethinking Photocatalysis

Catalysis: Study questions conventionally ascribed role of metal particles on semiconductors
(p.11)
 

Departments

09221-cover-LonzaFlowPlatecxd

Business

After a slow start, pharmaceutical and fine chemicals manufacturers are scaling up continuous processes for production
(pp. 13-21)
Shenhua addresses Greenpeace’s concerns that a coal-to-fuels project harms the environment
(pp. 33-34)
Patient groups are finding new models for funding drug development for their diseases
(pp. 27-28)
Chemical firms are taking over facilities freed up because of drug industry consolidation
(pp. 29-30)
Despite challenges, Albemarle and Chemtura increase their commitment to the bromine chemicals business
(pp. 31-32)
09221-govpol1-map_16699967350

Government & Policy

Misplaced research incentives and poor experimental design lead to studies that can’t be replicated
(pp. 38-39)
Democrats fear market-opening pacts would erode U.S. jobs
(pp. 36-37)
09221-scitech1-nanocxd_16691163690

Science & Technology

Characterizing animal models isn’t glamorous, says ALS Therapy Development Institute’s CEO, but it’s critical to bringing medicines to market
(p.51)
A look at recent patenting activity in 3-D printing in biomedical engineering applications, brought to you by C&EN and CAS
(p.53)
In peer-reviewed papers and on blogs, researchers argue over the existence of striped coatings on nanoparticles
(pp. 43-45)
With little medical input and supply challenges, states struggle to ensure capital punishment is neither cruel nor unusual
(pp. 46-48)

Career & Employment

Drug firms’ chemistry leaders describe the educational training that they seek in new recruits
(pp. 65-69)

Editor's Page